{"id":90024,"date":"2026-11-08T00:12:20","date_gmt":"2026-11-08T00:12:20","guid":{"rendered":"https:\/\/wallstreetresearch.org\/wsr\/?p=90024"},"modified":"2026-11-08T00:12:20","modified_gmt":"2026-11-08T00:12:20","slug":"chineseinvestors-com-corporate-profile-2019","status":"publish","type":"wsr_report","link":"https:\/\/wallstreetresearch.org\/wsr\/research\/chineseinvestors-com-corporate-profile-2019\/","title":{"rendered":"ChineseInvestors.com, Inc.: Corporate Profile"},"content":{"rendered":"<p>Founded in 1999, ChineseInvestors.com, Inc. (CIIX) is described in the report as the premier provider of financial news and education for the Chinese-speaking community, with more than 100,000 subscribers to its information portal, ChineseFN.com. Headquartered in San Gabriel, California, it also has offices in New York City, Richmond (Vancouver) BC and Shanghai. Its main revenue has come from subscriptions to financial news and information services covering investment education, news and real-time market analysis, and it also provides investor relations services, especially for companies needing Mandarin-language support.<\/p>\n<p>In recent years the Company saw an opportunity in the industrial hemp and CBD market and in 2017 set up two wholly owned consumer product subsidiaries, in the U.S. and China, which became major growth drivers. In May 2019 its subsidiary CBD Biotechnology Co. Ltd. exhibited its self-branded, hemp-infused skin care line at the 29th Vietnam Expo in Hanoi.<\/p>\n<p>OTCQB: CIIX \u00b7 Financial media and CBD products<\/p>\n<p><a href=\"https:\/\/www.wallstreetresearch.org\/reports\/CIIX_June11_2019_FINAL.pdf\">Read the corporate profile (PDF, 2 pages)<\/a><\/p>\n<p>Company website: <a href=\"http:\/\/www.chinesefn.com\" target=\"_blank\" rel=\"noopener\">chinesefn.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Its CBD Biotechnology Co. Ltd. exhibited a self branded, hemp infused skin care line at the 29th Vietnam Expo in Hanoi in May 2019.<\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","meta":{"wsr_company":"ChineseInvestors.com, Inc.","wsr_report_label":"Corporate Profile","wsr_report_kind":"profile","wsr_report_url":"https:\/\/www.wallstreetresearch.org\/reports\/CIIX_June11_2019_FINAL.pdf","wsr_report_pages":"2","wsr_report_date":"2019-06-11","wsr_report_undated":"","wsr_report_date_shown":"June 11, 2019","wsr_listing":"OTCQB: CIIX","wsr_market":"otc","wsr_symbol":"CIIX","wsr_ticker":"CIIX","wsr_exchange":"OTCQB","wsr_industry":"Financial media and CBD products","wsr_website":"http:\/\/www.chinesefn.com","wsr_milestone":"","wsr_logo":"l-ciix.webp","wsr_cover_image":"cv-ciix.webp","wsr_featured":"","wsr_in_cards":"1","wsr_track":"","wsr_track_priority":"","wsr_track_tile":"","wsr_track_only":"","footnotes":""},"tags":[26,69,62],"class_list":["post-90024","wsr_report","type-wsr_report","status-publish","hentry","tag-cannabis","tag-chineseinvestors-com","tag-media"],"_links":{"self":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/wsr_report\/90024","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/wsr_report"}],"about":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/types\/wsr_report"}],"author":[{"embeddable":true,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/wsr_report\/90024\/revisions"}],"predecessor-version":[{"id":97052,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/wsr_report\/90024\/revisions\/97052"}],"wp:attachment":[{"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/media?parent=90024"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wallstreetresearch.org\/wsr\/wp-json\/wp\/v2\/tags?post=90024"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}